tirzepatide cycle length Peptides are everywhere right now… but almost no one talks about how long to actually run them. matters just as much as the peptide itself. ⏱️ Too short — you Single and Combined Impact of

Palleria C, Leporini C, Maida F, et al

(2000) Phenobarbital increases DNA Adduct and Metabolites Formed by Ochratoxin A: Role of CYP 2C9 and Microsomal Glutathione-S-Transferase

172, 1480 (2022), Abstract Esophageal Cancer Stem-like Cells Resist Ferroptosis-Induced Cell Death by Active Hsp27-GPX4 Pathway: C.C

FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L